Connect with us

Artificial Intelligence

Global Uninterruptible Power Supply (UPS) Systems Industry

GlobeNewswire

Published

on

New York, July 10, 2020 (GLOBE NEWSWIRE) — Reportlinker.com announces the release of the report “Global Uninterruptible Power Supply (UPS) Systems Industry” – https://www.reportlinker.com/p05478468/?utm_source=GNW
7 Billion in the year 2020, is projected to reach a revised size of US$16.6 Billion by 2027, growing at a CAGR of 5.2% over the analysis period 2020-2027.Upto 5 kVA, one of the segments analyzed in the report, is projected to grow at a 5.2% CAGR to reach US$6.5 Billion by the end of the analysis period.After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the 5.1 to 20 kVA segment is readjusted to a revised 4.7% CAGR for the next 7-year period. This segment currently accounts for a 17.8% share of the global Uninterruptible Power Supply (UPS) Systems market.
ABB Ltd.APC by Schneider ElectricConsul Neowatt Power Solutions Pvt. Ltd.CyberPower Systems, Inc.Delta Electronics, Inc.East Group Co., Ltd.Eaton Corporation PlcEmerson Electric Co.,Fuji Electric Co., Ltd.General Electric CompanyHuawei Technologies Co. Ltd.LegrandNumeric Power Systems Ltd.Piller Group GmbHRPS SpaSchneider ElectricShenzhen KSTAR Science and Technology Co., Ltd.Socomec GroupToshiba International Corp.Tripp LiteXiamen Kehua Hengsheng Co., Ltd.Clare: clare@reportlinker.com
US: (339)-368-6001
Intl: +1 339-368-6001

GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Artificial Intelligence

Ureteroscope Market to Touch $1,498.1 Million by 2027; Increasing Demand for Efficient Kidney Stone Removal Devices Worldwide to Aid Market Growth: Fortune Business Insights™

GlobeNewswire

Published

on

Pune, Aug. 14, 2020 (GLOBE NEWSWIRE) — The global ureteroscope market size is projected to reach USD 1,498.1 million by 2027, exhibiting a CAGR of 5.5% during the forecast period. Increasing incidence of kidney stones is expected to stoke adoption of these devices, states Fortune Business Insights™ in its report, titled “Ureteroscope Market Size, Share & COVID-19 Impact Analysis, By Product (Flexible, Semi-flexible, and Rigid), By Application (Urolithiasis, Urolithial Carcinoma, and Others), End User (Hospitals, Specialty Clinics, and Others), and Regional Forecast, 2020-2027”.

A study published by the US National Institutes of Health (NIH) in 2018 revealed that kidney stone disease prevalence and its recurrence is rising. According to the study, 12% of the global population suffers from urolithiasis, which is the process of formation of stones, at some point during their lifetime. Affecting all races, sexes, and age groups, the disease is evidenced to be more prevalent in men than women. Ureteroscope aid in treating stone diseases as they help in pinpointing the location of the stone formation and help remove them efficiently. Thus, the growing prevalence of urolithiasis (or nephrolithiasis) is anticipated to boost the adoption of these devices in the coming years.

Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/ureteroscope-market-103455

As per the report findings, the global ureterscopy market value stood at USD 981.8 million in 2019. Aside from this, the report provides the following:

  • Panoramic overview of the general industry trends and outlook;
  • Detailed analysis of the factors shaping the market size, share, and overall growth;
  • Thorough evaluation of the market segments; and
  • In-depth research into the regional developments and competitive dynamics of the market.

Market Driver

Close Linkage between Diabetes and Kidney Stones to Support Market Growth

Kidney stones, or renal calculi, are crystal mass formations that can originate anywhere along the urinary tract. These stones are of various types such as calcium, uric acid, struvite, and cysteine. Research has found that diabetes is one of the most common risk factors for developing kidney stone because the high blood sugar levels in diabetics make their blood more acidic, creating the ideal environment for stones to form. According to the medical journal European Urology, people with type 2 diabetes having high insulin resistance are 92% more likely to form kidney stones than non-diabetic people. With diabetes expected to become more widespread in the coming decades, the demand for stone removal procedures is likely to rise and boost the ureteroscopes market growth in the process.

The global economy is in absolute turmoil because of the COVID-19 pandemic outbreak. Some industries remain largely unaffected by the outbreak, some are thriving, but most are in doldrums. Although the healthcare industry is flourishing, certain markets within the industry are experiencing staggered growth. Wading through these troubled times is a difficult task and Fortune Business Insights™ aims at equipping your business with the most comprehensive market insights, collated and analyzed by our expert and experienced research team.


Click here to get the short-term and long-term impact of COVID-19 on this market.

Please visit: https://www.fortunebusinessinsights.com/ureteroscope-market-103455

Regional Insights

Robust Healthcare Infrastructure to be the Key Driving Factor for North America

The US and Canada boast of a strong and developed healthcare infrastructure, with health facilities actively adopting modern medical devices and technologies. This is additionally bolstered by favorable reimbursement policies and growing demand for advanced medical procedures. Together, these factors enabled the market size in the region to reach USD 370.1 million and have a share of 37.7% in 2019. Based on these numbers, it is expected that the region will further strengthen its hold on the ureteroscope market share during the forecast period.

In Asia Pacific, the market is anticipated to expand at a considerable rate owing to increasing presence of global companies in developing countries such as India and China. Improving healthcare expenditure is also aiding the regional market growth.

Competitive Landscape

Key Players to Concentrate on Widening Distribution Networks

One of the key focus areas for players in the ureteroscope market is the development and expansion of their global distribution networks. In pursuit of this goal, most companies in this market are collaborating or acquiring regional players to establish their foothold in foreign markets.

Quick Buy –  Ureteroscope Market Research Report: https://www.fortunebusinessinsights.com/checkout-page/103455

Industry Developments:

  • November 2019: Olympus Corporation inked a deal with the Monaco-based medical products company, Rocamed, to distribute the RocaFlow Double Chamber Pump System and Tubing Sets in Europe. The set includes ureteroscopes for kidney stones and trans-urethral resection of the prostate.
  • April 2019: Dornier MedTech commercially released its innovative AXIS™ Single-Use Digital Flexible Ureteroscopes and other stone management products in the US. AXIS has been specifically designed to prevent cross-contamination between patients by ensuring a clean, sterile ureteroscope for every patient.


List of the Leading Companies Operating in the Ureteroscope Market are:

  • AED.MD (CA, USA)
  • PENTAX Medical (Tokyo, Japan)
  • Richard Wolf GmbH. (Illinois, United States)
  • Stryker (Michigan, United States)
  • Elmed Electronics & Medical Industry & Trade Inc. (Ankara, Turkey)
  • KARL STORZ (Tuttlingen, Germany)
  • Olympus Corporation (Tokyo, Japan)


Have Any Query? Ask Our Experts:
https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/ureteroscope-market-103455

Detailed Table of Content:

  • Introduction
    • Research Scope
    • Market Segmentation
    • Research Methodology
    • Definitions and Assumptions
  • Executive Summary
  • Market Dynamics
    • Market Drivers
    • Market Restraints
    • Market Opportunities
  • Key Insights
    • Prevalence of Urolithiasis, By Country/Region
    • Technological Advancements in Ureteroscope
    • Recent Industry Developments (Mergers, Partnerships, and Acquisitions)
    • Impact of COVID-19 on Ureteroscope Market
  • Global Ureteroscope Market Analysis, Insights and Forecast, 2016-2027
    • Key Findings / Summary
    • Market Analysis, Insights and Forecast – By Product
      • Flexible
      • Semi-flexible
      • Rigid
    • Market Analysis, Insights and Forecast – By Application
      • Urolithiasis
      • Urolithial Cancer
      • Others
    • Market Analysis, Insights and Forecast – By End User
      • Hospitals
      • Specialty Clinics
      • Others
    • Market Analysis, Insights and Forecast – By Region
      • North America
      • Europe
      • Asia Pacific
      • Latin America
      • Middle East & Africa

TOC Continued….!

Get your Customized Research Report: https://www.fortunebusinessinsights.com/enquiry/customization/ureteroscope-market-103455

Have a Look at Related Reports:

Urinary Catheter Market Size, Share & Industry Analysis, By Product (Indwelling Catheters, Intermittent Catheters, and External Catheters), By Application (Urinary Incontinence, Benign Prostatic Hyperplasia (BPH), Surgery, and Others), By Gender (Female, Male), By End User (Hospitals, Age Care Centers, and Others) and Regional Forecast 2019-2026

Urinary Drainage Bags Market Size, Share & Industry Analysis, By Product (Leg Bags and Large Capacity Bags), By Capacity (0-500 ml, 500-1000 ml, 1000-2000 ml, and more than 2000 ml), By Number of Chambers (Single Chamber, 2 Chamber, 3 Chamber), End-user (Hospitals, Clinics, Ambulatory Surgical Centers, Home Care, and Others), and Regional Forecast 2019-2026

Spinal Devices Market Size, Share & Industry Analysis, By Product Type (Fusion Devices (Cervical Devices, Thoracolumbar Devices, Interbody Devices, and Biologics), Non-Fusion Devices (Vertebral Compression Fracture Devices, Artificial Discs, Dynamic Stabilization Devices, and Others), and Stimulation Devices) By Disease Indication (Degenerative Disc Disease, Complex Deformity, Traumas & Fractures, and Others)

Cardiovascular Drugs Market Size, Share & Industry Analysis, By Drug Type (Antihypertensive, Antihyperlipidemic, Anticoagulants, Antiplatelet Drugs, Others), By Disease Indication (Hypertension, Hyperlipidemia, Coronary Artery Disease, Arrhythmia, Others), By Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies, Others) and Regional Forecast, 2019 -2026

Neurovascular Devices/Interventional Neurology Market Size, Share & Industry Analysis, By Device Type (Stenting Systems, Embolization Devices, Neurothrombectomy Devices, and Support Devices), By Application (Cerebral Aneurysms, Ischemic Stroke and Others), By End User (Hospitals, Specialty Clinics and Others), and Regional Forecast 2019-2026


About Us:

Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights™ we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

Contact Us:

Fortune Business Insights™ Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune – 411045, Maharashtra, India.

Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Email: sales@fortunebusinessinsights.com
Fortune Business Insights™
LinkedIn | Twitter | Blogs

Press Release: https://www.fortunebusinessinsights.com/press-release/global-ureteroscope-market-10160

Continue Reading

Artificial Intelligence

MobiusTrend: Hologram AR + Visual Technologies in e-Commerce

GlobeNewswire

Published

on

HONG KONG, Aug. 14, 2020 (GLOBE NEWSWIRE) — MobiusTrend, a market research organization in Hong Kong, recently released a research report on ‘Hologram AR + Visual Technologies in e-Commerce‘. It has been 20 years since the advent of Internet search engines. During this time, search methods and patterns have changed dramatically. Meanwhile, visual search has been on the rise in recent years, and it has overlapped with the image research on the technology, but they are not the same. Concerning the inputting, visual research usually refers to the pattern of using a smartphone or other types of cameras to identify information about all objects in the physical world. Then, the search engine uses image recognition technology to identify the valid information it represents and present it to the audience in an intelligently displayed manner in a specific visual display application.

Google Goggles can be treated as the earliest visual search app when it was launched in 2009 by Google. Moreover, it was first developed for Android smartphones and later for iOS in 2010. The Goggles aims to search for information that identifies objects in the real world and allows it to search for products using the bar code of an object.

Visual search has great commercial potential because its model is searching for what users want to buy in the most direct way, as well as to retrieve relevant product information. But the existing text search and voice search can only find a range of current objects, which are difficult to achieve precise retrieval.

AR also opens up a whole new world of visual search. Ikea has developed apps that use AR technology to show the size and placement of furniture. Users can freely decorate their own coffee table, wallpaper, and lighting fixtures. At the same time, visual search can also have more applications to the aspects of spatial detection, intelligent decoration, and spatial beautification. Through the more precise visual search and recognition technology, users can screen out a lot of effective information. Moreover, AI can also take this opportunity to collect user data and launch personalized, customized services.

Facial recognition technology is a kind of biometric identification technology, which is based on facial feature information. It uses camera equipment to collect facial images or videos and extracts facial image features for searching and matching with feature templates stored in the database. When the similarity exceeds the set threshold, successful matching results will be output; otherwise, unsuccessful matching results will be output. Face recognition is based on digital image processing, which has always been a frontier research direction. The later stage of digital image processing technology will develop into artificial intelligence (AI).

WIMI’s holographic system is an exclusive research and development breakthrough. WIMI’s leading WIMI AI face technology application has gained lots of praise in this industry. Phones, equipped with WIMI’s facial recognition technology, can use face swiping to unlock. Sound system, equipped with speech recognition and speech recognition technology, can achieve voice interaction.

WIMI’s holographic cloud is a content delivery manner of augmented reality. Meanwhile, it allows you to see and interact with three-dimensional images that combine the non-existing objects with the real world. The images are projected from a mobile phone or computer onto other media via projection devices. Besides, the most commercially valuable aspect of WIMI is holographic technology.

WIMI AI-MBT platform is a high-performance holographic cloud management platform, which is mainly used to provide AR+3D applications for customers. WIMI opens its API interface to premium customers. Through API interface, media platforms can develop customized system functions, including automatic management of advertising resources, advertising resource analysis and internal system integration, customized special functions, a single platform to manage multiple accounts and a series of other functions. Media platforms can display their advertising space resources in an all-round way in front of advertisers.

There are some differences between AR search and visual search. Visual search refers to a search that uses the real world as input information of any objects. But the feedback of search results is limited to the device being used while guiding the users to visit web pages or applications. AR search is to enhance users’ cognition of the world around them, by superimposing information or visual effects on the surrounding environment and searching visual input and information output.

With the arrival of 5G commercial use and artificial intelligence, the Internet of everything is just around the corner. The accelerated development of visual networking will be conducive to the maturity and upgrading of the AR glasses industry. With the constant upgrade of intelligent hardware, the vigorous development of application ecology, and the continuous improvement of public awareness, the AR smart glasses industry will be greeted with rapid growth in a day.

About MobiusTrend

MobiusTrend Group is a leading market research organization in Hong Kong. They have built one of the premier proprietary research platforms on the financial market, emphasizing on emerging growth companies and paradigm-shifting businesses. MobiusTrend team is professional in market research reports, industry insights, and financing trends analysis. For more information, please visit http://www.mobiustrend.com/

Media contact

Company: MobiusTrend Research

Contact: Trends & Insights Team

E-Mail: cs@mobiustrend.com

Website: http://www.mobiusTrend.com

Youtube: https://www.youtube.com/channel/UCOlz-sCOlPTJ_24rMgR6JLw

 

Continue Reading

Artificial Intelligence

Predictive Oncology Announces DojoLIVE! Interview with Helomics CIO Mark Collins, ‘Can We Cure Cancer with Artificial Intelligence?’

GlobeNewswire

Published

on

LOS ANGELES, Aug. 14, 2020 (GLOBE NEWSWIRE) — via NetworkWire — Predictive Oncology Inc. (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, today announces that Mark Collins, Ph.D., chief innovation officer of its Helomics subsidiary, recently appeared on DojoLIVE!, a lively podcast and interview forum that brings together a broad roster of technology, business and thought leaders from a wide range of software companies and startups.

The broadcast, titled ‘Can We Cure Cancer With Artificial Intelligence?’, is available for on-demand viewing on the DojoLIVE! website.

As noted during the interview, Collins possesses a passion for applying science to build high-tech life-science products and services that impact the search for new medicines. He feels that Helomics, a division of Predictive Oncology, is uniquely positioned to deliver on this goal.

Helomics aims to improve outcomes for the cancer patients of today and in the future by harnessing the power of the patient’s own living tumor. The company uses its unique clinically validated Tumor Drug Response Profiling (TDRP) platform to generate a comprehensive profile of the patient tumor to guide the oncologist in individualizing treatment. In use for 15+ years, this platform has generated drug response and genomic profiles on over 150,000 tumors – the largest knowledgebase of its kind in the world.

Helomics is leveraging this unique TDRP platform and huge knowledge base to pioneer the development of AI-driven models of tumor drug response and outcome that, in partnership with pharmaceutical companies, will enable lower cost, faster and smarter discovery of new therapies. Furthermore, once validated, these AI-models will be used as clinical decision support tools to help clinicians individualize cancer treatment with current therapies.

About Predictive Oncology Inc.

Predictive Oncology (NASDAQ: POAI) operates through three segments (Domestic, International and other), which contain four subsidiaries; Helomics, TumorGenesis, Skyline Medical and Skyline Europe. Helomics applies artificial intelligence to its rich data gathered from patient tumors to both personalize cancer therapies for patients and drive the development of new targeted therapies in collaborations with pharmaceutical companies. Helomics’ CLIA-certified lab provides clinical testing that assists oncologists in individualizing patient treatment decisions, by providing an evidence-based roadmap for therapy. In addition to its proprietary precision oncology platform, Helomics offers boutique CRO services that leverage its TruTumor™, patient-derived tumor models coupled to a wide range of multi-omics assays (genomics, proteomics and biochemical), and an AI-powered proprietary bioinformatics platform to provide a tailored solution to its clients’ specific needs.

Predictive Oncology’s TumorGenesis subsidiary is developing a new rapid approach to growing tumors in the laboratory, which essentially “fools” cancer cells into thinking they are still growing inside a patient. Its proprietary Oncology Discovery Technology Platform kits will assist researchers and clinicians to identify which cancer cells bind to specific biomarkers. Once the biomarkers are identified they can be used in TumorGenesis’ Oncology Capture Technology Platforms, which isolate and help categorize an individual patient’s heterogeneous tumor samples to enable the development of patient specific treatment options. Helomics and TumorGenesis are focused on ovarian cancer. Predictive Oncology’s Skyline Medical division markets its patented and FDA cleared STREAMWAY System, which automates the collection, measurement and disposal of waste fluid, including blood, irrigation fluid and others, within a medical facility, through both domestic and international divisions. The company has achieved sales on five of the seven continents through both direct sales and distributor partners. For more information, please visit www.Predictive-Oncology.com.

Forward-Looking Statements

This release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. All forward-looking statements are inherently uncertain as they are based on current expectations and assumptions concerning future events or future performance of the company. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. In evaluating such statements, prospective investors should review carefully various risks and uncertainties identified in this release and matters set in the company’s SEC filings. These risks and uncertainties could cause the company’s actual results to differ materially from those indicated in the forward-looking statements.

Corporate Communications

InvestorBrandNetwork (IBN)
Los Angeles, California
www.InvestorBrandNetwork.com
310.299.1717 Office
Editor@InvestorBrandNetwork.com 

Continue Reading

Trending

Roboticulized is part of PICANTE Media and Events, a leading media and boutique event organizer in the European Union with a monthly reach of +50,000 readers. The official company (PROSHIRT SRL), has been listed for 4 years in a row among the top 3 Advertising and market research agencies in the local Top Business Romania Microcompanies based on the Financial Reports. Roboticulized digests / hand picks the latest news about the AI industry and serves them to you daily.

Contact us: sales@picante.today

Editorial / PR Submissions

© Roboticulized.com 2019 - 2020 - part of PICANTE Media. All rights reserved. Registered in Romania under Proshirt SRL, Company number: 2134306, EU VAT ID: RO21343605. Office address: Blvd. 1 Decembrie 1918 nr.5, Targu Mures, Romania